Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation-Reference-Cited by-同舟云学术

Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation

Published:2016-06 Issue:6 Volume:36 Page:358-366
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Miuma Satoshi¹,Ichikawa Tatsuki¹²,Miyaaki Hisamitsu¹,Haraguchi Masafumi¹,Tamada Yoko¹,Shibata Hidetaka¹,Taura Naota¹,Soyama Akihiko³,Hidaka Masaaki³,Takatsuki Mitsuhisa³,Eguchi Susumu³,Nakao Kazuhiko¹

Affiliation:

1. Department of Gastroenterology, Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

2. Department of Gastroenterology, Nagasaki Harbor Medical Center City Hospital, Nagasaki, Japan.

3. Department of Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2015.0147

Reference44 articles.

1. Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection